We are live on
!
Find out more
QCG
Quadrant Capital Group Portfolio holdings
AUM
$3.34B
1-Year Est. Return
29.16%
This Fund
S&P 500
This Quarter
Est. Return
+9.35%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$3.08B
AUM Growth
+$298M
(+11%)
Cap. Flow
+$91.4M
Cap. Flow
% of AUM
2.97%
Top 10 Holdings %
Top 10 Hldgs %
29.39%
Holding
2,686
New
1,350
Increased
669
Reduced
478
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$11.9M |
| 2 |
PepsiCo
PEP
|
+$6.06M |
| 3 |
NVIDIA
NVDA
|
+$5.4M |
| 4 |
Microsoft
MSFT
|
+$4.52M |
| 5 |
UnitedHealth
UNH
|
+$3.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$8.26M |
| 2 |
HDFC Bank
HDB
|
+$4.53M |
| 3 |
HSBC
HSBC
|
+$4.45M |
| 4 |
ICICI Bank
IBN
|
+$3.79M |
| 5 |
BHP
BHP
|
+$2.29M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.23% |
| 2 | Financials | 12.32% |
| 3 | Consumer Discretionary | 8.41% |
| 4 | Healthcare | 7.24% |
| 5 | Industrials | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Atlanta Braves Holdings Series B
BATRK
$3.23B
| $1.37K | ﹤0.01% |
+33
| New | +$1.46K |
|
2527
Myriad Genetics
MYGN
$530M
| $1.37K | ﹤0.01% |
+189
| New | +$1.12K |
|
2528
Bowman Consulting
BWMN
$454M
| $1.36K | ﹤0.01% |
+32
| New | +$1.2K |
|
|
XOMA
2529
DELISTED
Xoma
XOMA
| $1.35K | ﹤0.01% |
+35
| New | +$1.09K |
|
2530
V2X
VVX
$2.62B
| $1.34K | ﹤0.01% |
+23
| New | +$1.23K |
|
2531
Photronics
PLAB
$1.79B
| $1.33K | ﹤0.01% |
+58
| New | +$1.24K |
|
|
CTEV
2532
Claritev Corp
CTEV
$368M
| $1.33K | ﹤0.01% |
+25
| New | +$1.38K |
|
2533
SI-BONE Inc
SIBN
$737M
| $1.31K | ﹤0.01% |
+89
| New | +$1.45K |
|
2534
Ardagh Metal Packaging
AMBP
$2.86B
| $1.3K | ﹤0.01% |
+326
| New | +$1.3K |
|
2535
Immunovant
IMVT
$8.09B
| $1.29K | ﹤0.01% |
+80
| New | +$1.29K |
|
2536
Invesco WilderHill Clean Energy ETF
PBW
$390M
| $1.27K | ﹤0.01% |
+44
| New | +$1.09K |
|
2537
Conduent
CNDT
$230M
| $1.27K | ﹤0.01% |
+453
| New | +$1.23K |
|
2538
Arbutus Biopharma
ABUS
$865M
| $1.26K | ﹤0.01% |
+277
| New | +$1.02K |
|
2539
Gogo Inc
GOGO
$515M
| $1.25K | ﹤0.01% |
+145
| New | +$1.84K |
|
2540
FRP Holdings
FRPH
$449M
| $1.24K | ﹤0.01% |
+51
| New | +$1.32K |
|
|
FBRT
2541
Franklin BSP Realty Trust
FBRT
$601M
| $1.24K | ﹤0.01% |
+114
| New | +$1.26K |
|
|
HOUS
2542
DELISTED
Anywhere Real Estate
HOUS
| $1.23K | ﹤0.01% |
+116
| New | +$682 |
|
|
XYF
2543
X Financial
XYF
$184M
| $1.23K | ﹤0.01% |
+89
| New | +$1.37K |
|
2544
Regenxbio
RGNX
$623M
| $1.22K | ﹤0.01% |
+126
| New | +$1.11K |
|
|
KREF
2545
KKR Real Estate Finance Trust
KREF
$472M
| $1.21K | ﹤0.01% |
+134
| New | +$1.25K |
|
2546
Acadia Pharmaceuticals
ACAD
$4.25B
| $1.2K | ﹤0.01% |
+56
| New | +$1.32K |
|
2547
MarineMax
HZO
$800M
| $1.19K | ﹤0.01% |
+47
| New | +$1.2K |
|
2548
Axogen
AXGN
$2.1B
| $1.18K | ﹤0.01% |
+66
| New | +$958 |
|
|
ACLX
2549
DELISTED
Arcellx
ACLX
| $1.15K | ﹤0.01% |
+14
| New | +$1.01K |
|
|
KW
2550
DELISTED
Kennedy-Wilson Holdings
KW
| $1.11K | ﹤0.01% |
+134
| New | +$1.07K |
|
Similar funds
BDLIB
CS
ECA
TAM
5NCM
DIA
HP
EFM
Quadrant Capital Group's Q3 2025 Portfolio in Review
As of Q3 2025, Quadrant Capital Group held 2,686 positions worth $3.08B, up 11% from $2.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Quadrant Capital Group's Q3 2025 filing shows 1,350 new, 669 increased, 478 reduced and 12 closed positions. Its largest new stake was Coupang: 57,787 shares worth $1.86M. The largest sale was JPMorgan Ultra-Short Income ETF, an estimated $8.26M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
- Quadrant Capital Group's largest Q3 2025 buy was Coupang: 57,787 shares worth $1.86M.
- Quadrant Capital Group added most to Apple in Q3 2025, an estimated $11.9M increase.
- Quadrant Capital Group's biggest Q3 2025 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $8.26M.
- Quadrant Capital Group fully exited Ansys in Q3 2025, selling an estimated $891K.
- Quadrant Capital Group's ten largest holdings make up 29% of its $3.08B portfolio in Q3 2025.
- Quadrant Capital Group opened 1,350 new positions and closed 12 in Q3 2025.
- Quadrant Capital Group's portfolio value rose 11% quarter-over-quarter to $3.08B.
Based on Quadrant Capital Group's 13F filing for Q3 2025, filed 13 Nov 2025.